Pasithea Therapeutics Corp.
KTTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,037 | -$3,716 | -$3,563 | -$3,178 |
| Dep. & Amort. | $182 | $162 | $162 | $162 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$143 | -$380 | $316 | $455 |
| Other Non-Cash | $109 | $66 | $30 | $117 |
| Operating Cash Flow | -$2,890 | -$3,869 | -$3,056 | -$2,443 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$116 | -$114 | -$179 | $0 |
| Stock Issued | $0 | $5,853 | $1,654 | -$24 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$116 | $5,739 | $1,474 | -$24 |
| Forex Effect | $13 | $6 | $0 | $28 |
| Net Chg. in Cash | -$2,994 | $1,876 | -$1,581 | -$2,438 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,217 | $5,341 | $6,923 | $9,361 |
| End Cash | $4,224 | $7,217 | $5,341 | $6,923 |
| Free Cash Flow | -$2,890 | -$3,869 | -$3,056 | -$2,443 |